BiotechTube
Home/Kala Pharmaceuticals/Eric L. Trachtenberg
EL

Eric L. Trachtenberg

General Counsel and Secretary

Kala Pharmaceuticals

Therapeutic Areas

OphthalmologyRare Diseases

Kala Pharmaceuticals Pipeline

DrugIndicationPhase
KPI-012Persistent Corneal Epithelial Defect (PCED)Phase 2b
KPI-014Inherited Retinal DegenerationsPreclinical

Leadership Team at Kala Pharmaceuticals

MI
Mark Iwicki
Chairman, President and Chief Executive Officer
MK
Meredith Kaya
Vice President, Clinical Development
KB
Kimberly Brown
Vice President, Operations
View full Kala Pharmaceuticals profile